Oracle Unveils Fusion Claw + Expands Agentic Applications: NYSE Content Update
PR Newswire•29/09/2026•08:55 ET
2
Key Highlights
- ➤Oracle introduces Fusion Claw for autonomous complex work at scale
- ➤Oracle expands offering with 25 new agentic applications
- ➤Envisagenics partners with Boehringer Ingelheim on precision cancer targets
- ➤U.S. 10-year Treasury yield ended Monday above 5.2%
- ➤Bloom Energy (BE) celebrates its 25th anniversary of founding
Expert Statements
Chris Leone, EVP of Applications Development at Oracle
“The new offering will enable customers to drive growth and serve customers.”
Maria Luisa Pineda, Co-founder and CEO of Envisagenics
“It's looking to transform alternative RNA splicing to engineer a new era of drug discovery.”
Oracle Unveils Fusion Claw + Expands Agentic Applications: NYSE Content Update PR Newswire
NYSE issues a pre-market daily advisory direct from the trading floor.
Get started
Create a free account to read the full story.